Close

Osmotica Pharma (OSMT) Announces Positive Topline Results of Phase III Clinical Trials of RVL-1201 for Acquired Blepharoptosis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. SPY
6. HCP
7. BSX
8. NOW
9. SNAP
10. PI


Go back to Osmotica Pharma (OSMT) Announces Positive Topline Results of Phase III Clinical Trials of RVL-1201 for Acquired Blepharoptosis

Osmotica Pharmaceuticals plc (OSMT) Halted, News Pending

May 6, 2019 4:25 PM EDT

Osmotica Pharmaceuticals plc (NASDAQ: OSMT) Halted, News Pending

... More